Anke Klippel

9.7k total citations · 3 hit papers
67 papers, 8.0k citations indexed

About

Anke Klippel is a scholar working on Molecular Biology, Oncology and Cell Biology. According to data from OpenAlex, Anke Klippel has authored 67 papers receiving a total of 8.0k indexed citations (citations by other indexed papers that have themselves been cited), including 58 papers in Molecular Biology, 14 papers in Oncology and 13 papers in Cell Biology. Recurrent topics in Anke Klippel's work include Protein Kinase Regulation and GTPase Signaling (22 papers), PI3K/AKT/mTOR signaling in cancer (14 papers) and Multiple Myeloma Research and Treatments (10 papers). Anke Klippel is often cited by papers focused on Protein Kinase Regulation and GTPase Signaling (22 papers), PI3K/AKT/mTOR signaling in cancer (14 papers) and Multiple Myeloma Research and Treatments (10 papers). Anke Klippel collaborates with scholars based in United States, Germany and Switzerland. Anke Klippel's co-authors include Lewis T. Williams, George Kulik, Michael J. Weber, W. Michael Kavanaugh, Christoph Reinhard, Wendy J. Fantl, Qianjin Hu, Anthony J. Muslin, David Pot and J A Escobedo and has published in prestigious journals such as Science, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Anke Klippel

67 papers receiving 7.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Caspase-3-Generated Fragment of Gelsolin: Effector of Morphological Change in Apoptosis

1997 1.0k citations Anke Klippel, Lewis T. Williams et al. profile →
Antiapoptotic Signalling by the Insulin-Like Growth Factor I Receptor, Phosphatidylinositol 3-Kinase, and Akt

1997 933 citations George Kulik, Anke Klippel et al. Molecular and Cellular Biology profile →
Immunomodulatory agents lenalidomide and pomalidomide co‐stimulate T cells by inducing degradation of T cell repressors I karos and A iolos via modulation of the E 3 ubiquitin ligase complex CRL 4 ^CRBN

2013 457 citations Anita K. Gandhi, Jian Kang et al. British Journal of Haematology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Anke Klippel United States	40	6.2k	1.3k	1.3k	967	831	67	8.0k
Luisa Lanfrancone Italy	38	4.9k 0.8×	839 0.7×	1.6k 1.3×	1.2k 1.3×	813 1.0×	95	7.8k
Robert Latek United States	17	5.4k 0.9×	812 0.6×	936 0.7×	1.2k 1.2×	509 0.6×	31	7.6k
Thomas O. Daniel United States	38	4.6k 0.7×	966 0.8×	1.4k 1.1×	1.2k 1.3×	758 0.9×	58	7.2k
W. J. Pledger United States	42	5.0k 0.8×	1.2k 1.0×	2.5k 2.0×	735 0.8×	1.0k 1.2×	114	7.9k
Peter van der Geer United States	38	5.5k 0.9×	1.9k 1.5×	1.5k 1.2×	1.3k 1.4×	920 1.1×	62	8.3k
Alan P. Fields United States	54	6.1k 1.0×	1.4k 1.1×	1.8k 1.5×	612 0.6×	1.1k 1.3×	120	7.9k
Martin Friedlander United States	48	5.6k 0.9×	736 0.6×	789 0.6×	890 0.9×	1.2k 1.5×	144	9.2k
Michael Fry United Kingdom	46	8.7k 1.4×	2.2k 1.8×	1.3k 1.0×	1.0k 1.0×	754 0.9×	99	10.8k
Vincent J. Kidd United States	47	5.3k 0.9×	1.1k 0.9×	2.0k 1.6×	856 0.9×	1.1k 1.4×	100	7.2k
Christian Rommel United States	44	7.3k 1.2×	1.0k 0.8×	1.7k 1.4×	2.1k 2.2×	913 1.1×	88	10.2k

Countries citing papers authored by Anke Klippel

Since Specialization

Citations

This map shows the geographic impact of Anke Klippel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anke Klippel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anke Klippel more than expected).

Fields of papers citing papers by Anke Klippel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anke Klippel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anke Klippel. The network helps show where Anke Klippel may publish in the future.

Co-authorship network of co-authors of Anke Klippel

This figure shows the co-authorship network connecting the top 25 collaborators of Anke Klippel. A scholar is included among the top collaborators of Anke Klippel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anke Klippel. Anke Klippel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hilton, John, Mihaela Cristea, Mark Voskoboynik, et al.. (2018). Initial results from a phase I/IIa trial evaluating BMS-986158, an inhibitor of the bromodomain and extra-terminal (BET) proteins, in patients (pts) with advanced cancer. Annals of Oncology. 29. viii134–viii134. 15 indexed citations

Dann, Stephen G., Anthony M. Barsotti, Jonathon Golas, et al.. (2015). Reciprocal regulation of amino acid import and epigenetic state through Lat1 and EZH 2. The EMBO Journal. 34(13). 1773–1785. 49 indexed citations

Gandhi, Anita K., Jian Kang, Courtney G. Havens, et al.. (2013). Immunomodulatory agents lenalidomide and pomalidomide co‐stimulate T cells by inducing degradation of T cell repressors I karos and A iolos via modulation of the E 3 ubiquitin ligase complex CRL 4 ^CRBN . British Journal of Haematology. 164(6). 811–821. 457 indexed citations breakdown →

Dann, Stephen G., Jonathon Golas, Miriam Miranda, et al.. (2013). p120 catenin is a key effector of a Ras-PKCɛ oncogenic signaling axis. Oncogene. 33(11). 1385–1394. 25 indexed citations

Ünsal-Kaçmaz, Keziban, Edward Rosfjord, Stephen G. Dann, et al.. (2011). The interaction of PKN3 with RhoC promotes malignant growth. Molecular Oncology. 6(3). 284–298. 39 indexed citations

Dzwonek, Joanna, Olena Preobrazhenska, Andrea Conidi, et al.. (2009). Smad3 Is a Key Nonredundant Mediator of Transforming Growth Factor β Signaling in Nme Mouse Mammary Epithelial Cells. Molecular Cancer Research. 7(8). 1342–1353. 24 indexed citations

Tondera, Daniel, Ansgar Santel, Rolf Schwarzer, et al.. (2004). Knockdown of MTP18, a Novel Phosphatidylinositol 3-Kinase-dependent Protein, Affects Mitochondrial Morphology and Induces Apoptosis. Journal of Biological Chemistry. 279(30). 31544–31555. 123 indexed citations

Schwarzer, Rolf, Daniel Tondera, W. Arnold, et al.. (2004). REDD1 integrates hypoxia-mediated survival signaling downstream of phosphatidylinositol 3-kinase. Oncogene. 24(7). 1138–1149. 111 indexed citations

Giese, Klaus, Jörg Kaufmann, Gijsbertus J. Pronk, & Anke Klippel. (2002). Unravelling novel intracellular pathways in cell-based assays. Drug Discovery Today. 7(3). 179–186. 24 indexed citations

10.

Krappmann, Daniel, Eunice N. Hatada, Jun Li, et al.. (2000). The IκB Kinase (IKK) Complex Is Tripartite and Contains IKKγ but Not IKAP as a Regular Component. Journal of Biological Chemistry. 275(38). 29779–29787. 97 indexed citations

11.

Burow, Matthew E., Christopher B. Weldon, Bridgette M. Collins‐Burow, et al.. (2000). Cross-talk between Phosphatidylinositol 3-Kinase and Sphingomyelinase Pathways as a Mechanism for Cell Survival/Death Decisions. Journal of Biological Chemistry. 275(13). 9628–9635. 57 indexed citations

12.

Jefferson, Anne B., Anke Klippel, & Lewis T. Williams. (1998). Inhibition of mSOS-activity by binding of phosphatidylinositol 4,5-P2 to the mSOS pleckstrin homology domain. Oncogene. 16(18). 2303–2310. 16 indexed citations

13.

Uddin, Shahab, et al.. (1998). Protein Kinase B/Akt Mediates Effects of Insulin on Hepatic Insulin-like Growth Factor-binding Protein-1 Gene Expression through a Conserved Insulin Response Sequence. Journal of Biological Chemistry. 273(11). 6482–6487. 150 indexed citations

14.

Kulik, George, Anke Klippel, & Michael J. Weber. (1997). Antiapoptotic Signalling by the Insulin-Like Growth Factor I Receptor, Phosphatidylinositol 3-Kinase, and Akt. Molecular and Cellular Biology. 17(3). 1595–1606. 933 indexed citations breakdown →

15.

Klippel, Anke, W. Michael Kavanaugh, David Pot, & Lewis T. Williams. (1997). A Specific Product of Phosphatidylinositol 3-Kinase Directly Activates the Protein Kinase Akt through Its Pleckstrin Homology Domain. Molecular and Cellular Biology. 17(1). 338–344. 423 indexed citations

16.

Kavanaugh, W. Michael, Christoph W. Turck, Anke Klippel, & Lewis T. Williams. (1994). Tyrosine 508 of the 85-Kilodalton Subunit of Phosphatidylinositol 3-Kinase Is Phosphorylated by the Platelet-Derived Growth Factor Receptor. Biochemistry. 33(36). 11046–11050. 22 indexed citations

17.

Klippel, Anke, J A Escobedo, Tatsuya Hirano, & L T Williams. (1994). The interaction of small domains between the subunits of phosphatidylinositol 3-kinase determines enzyme activity.. Molecular and Cellular Biology. 14(4). 2675–2685. 126 indexed citations

18.

Klippel, Anke, J A Escobedo, Qianjin Hu, & L T Williams. (1993). A region of the 85-kilodalton (kDa) subunit of phosphatidylinositol 3-kinase binds the 110-kDa catalytic subunit in vivo.. Molecular and Cellular Biology. 13(9). 5560–5566. 88 indexed citations

19.

Kavanaugh, W. Michael, Anke Klippel, Jaime A. Escobedo, & Lewis T. Williams. (1992). Modification of the 85-Kilodalton Subunit of Phosphatidylinositol-3 Kinase in Platelet-Derived Growth Factor-Stimulated Cells. Molecular and Cellular Biology. 12(8). 3415–3424. 20 indexed citations

20.

Klippel, Anke, et al.. (1988). Isolation and characterization of unusual gin mutants.. The EMBO Journal. 7(12). 3983–3989. 100 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact